NYSE$AMWL

American Well Corp · Q1 2025 earnings

Q1 2025 earnings · · After market close · Investor relations

Briefing

American Well reported Q1 2025, revenue of $66.8M, a net loss of $18.4M.

For Q1 2025, American Well reported revenue of $66.8M, a net loss of $18.4M. The filing highlights segment performance, liquidity, and management commentary on the period.

  • Revenue $66.8M.
  • Net loss $18.4M.
  • American Well discusses capital allocation and near-term priorities in MD&A.

Headline financials

Total Revenue

$66.8M

Previous: $59.5M+12.3%
EPS (adj)

-$1.19

Previous: -$5.00+76.2%
Total Visits

1.3M

No prior period
Gross Margin

53.0%

No prior period
Adjusted EBITDA

-$12.2M

No prior period
Capital Expenditures

-$9K

Previous: -$75K+88.0%
Net Income

-$18.7M

Previous: -$72.1M+74.1%
Operating Income

-$30.4M

Previous: -$75M+59.5%

Revenue & EPS history

American Well · Revenue · Quarterly

$66.8M

Q1 2025+12.3%vs Q1 2024
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Revenue by segment

American Well · $28.4M total across 1 segment · Q3 2023

  • Subscription Revenue
    $28.4M-11.0%

Forward guidance

Biotech discusses pipeline milestones, launch uptake, and cash runway rather than near-term profitability guidance.

Tailwinds

  • Commercial or collaboration revenue ramps.
  • Pipeline readouts and label expansions.
  • Cash and investment income extend runway.

Headwinds

  • R&D spend ahead of profitability.
  • Regulatory and trial timing risk.
  • Reimbursement and pricing pressure.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2025

Historical avgQ1 2025

+1.4%

Avg return

Earnings day

+2.1%

Avg return

5 days after

-2.2%

Avg return

30 days after

41%

9 / 22 earnings

Positive

+33.8%

Q2 2024

Best reaction

-20.9%

Q1 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.0%+27.2%+34.0%
Q4 2025+24.7%+34.9%+29.8%
Q3 2025-9.5%-20.0%-20.6%
Q1 2025+19.7%+9.5%+8.9%
Q4 2024-5.0%-3.6%-35.5%
Q3 2024-5.0%-5.4%-0.7%
Q2 2024+33.8%+13.9%-1.1%
Q1 2024+2.0%+11.4%-16.3%
Q4 2023+23.6%+20.8%-16.0%
Q3 2023+14.5%+4.3%+11.1%
Q2 2023-8.3%-13.9%-35.2%
Q1 2023-3.9%-2.9%+17.9%
Q4 2022-13.1%-19.2%-37.3%
Q3 2022-2.2%+14.9%-8.3%
Q2 2022+9.2%+6.8%-4.8%
Q1 2022-10.8%+8.8%+37.6%
Q4 2021+7.2%+1.0%-8.0%
Q3 2021-7.4%-3.7%-29.7%
Q2 2021+0.7%-1.7%+0.8%
Q1 2021-20.9%-5.7%+9.5%
Q4 2020-4.1%-10.8%-1.5%
Q3 2020-11.9%-19.8%+17.1%
Q2 2020
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro